SpyGlass Pharma management to present at H.C. Wainwright Global Investment Conference

• SpyGlass Pharma management will attend investor meetings at the Wells Fargo 21st Annual Healthcare Conference on Sept. 9, 2026.
• Participation continues Sept. 10, 2026 at Citi’s 2026 Biopharma Back to School Conference, including a 10:40 a.m. ET fireside chat.
• Schedule concludes Sept. 14, 2026 at the H.C. Wainwright 28th Annual Global Investment Conference, featuring a 1:30 p.m. ET presentation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spyglass Pharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609020800PRIMZONEFULLFEED9818897) on September 02, 2026, and is solely responsible for the information contained therein.